ALEXANDRIA, Va., July 16 -- United States Patent no. 12,357,627, issued on July 15, was assigned to AZURITY PHARMACEUTICALS INC. (Woburn, Mass.).
"Pharmaceutical compositions of cabozantinib" was invented by Sushant Omprakash Dube (Maharashtra, India), Suprit Dilip Saoji (Maharashtra, India), Pankaj Kisan Chatki (Telangana, India), Sumitra Ashokkumar Pillai (Telangana, India) and Girish G. Kore (Maharashtra, India).
According to the abstract* released by the U.S. Patent & Trademark Office: "Pharmaceutical compositions are provided, which comprise cabozantinib or pharmaceutically acceptable salts thereof, and at least one pharmaceutically acceptable excipient, wherein the inventive compositions exhibit enhanced bioavailability compared to ...